Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
UK-5099: Unveiling Mitochondrial Metabolism Control in Immun
2026-07-02
Explore how UK-5099, a potent mitochondrial pyruvate carrier inhibitor, revolutionizes immunometabolism research by enabling precise metabolic modulation in whole-blood assays. This article reveals advanced scientific insights and practical assay guidance beyond existing protocols.
-
1-Phenyl-2-Pentanol Suppresses Liver Fibrosis via HSC Modula
2026-07-02
This study demonstrates that 1-phenyl-2-pentanol from Moringa oleifera inhibits hepatic stellate cell activation and fibrotic signaling by targeting TGF-β1 and Wnt/β-catenin pathways. The findings highlight a promising anti-fibrotic strategy and inform future in vitro liver fibrosis models.
-
Triiodothyronine (T3): Driving Next-Gen Metabolic Research
2026-07-01
Explore how Triiodothyronine (T3) enables breakthroughs in metabolic regulation and adipocyte differentiation, integrating mechanistic insights from SEMA3E-β-catenin signaling and providing strategic guidance for translational researchers. This article bridges the gap between bench and bedside, highlighting workflow parameters and competitive advantages for advanced thyroid hormone signaling studies.
-
Amiloride (MK-870): Pushing Boundaries in Sodium Channel and
2026-07-01
Explore the advanced scientific underpinnings of Amiloride (MK-870) as a sodium channel inhibitor, with a focus on its unique dual action and emerging applications in microenvironmental and immunological research. This article offers fresh, practical insights distinct from previous content.
-
Dextran Microgels for Oral Nanotherapeutic Delivery in Colon
2026-06-30
This study introduces a dual-targeted delivery system using microfluidized dextran microgels encapsulating cisplatin- and SPION-loaded lipid nanoparticles for oral treatment of colorectal cancer. The design enhances colon-specific drug release and tumor cell uptake, demonstrating significant tumor suppression and reduced metastasis in preclinical models.
-
Neuroligin 1 Proteolysis Drives Social Memory Maintenance in
2026-06-30
Liu et al. reveal that proteolytic fragments of neuroligin 1, generated during social interactions, are essential for sustaining social memory in mice. This work uncovers a molecular mechanism linking extracellular cleavage events to synaptic remodeling and memory persistence, with implications for understanding neuropsychiatric disorders.
-
Macrophage Membrane Nanoparticles Enable Synergistic GBM The
2026-06-29
This study introduces macrophage membrane-camouflaged nanoparticles co-delivering siSTAT3 and a photosensitizer, enabling efficient blood–brain barrier penetration and synergistic gene-phototherapy against glioblastoma. The findings establish a robust preclinical basis for targeted, minimally invasive brain tumor treatment and offer a reference model for translational nanomedicine strategies.
-
FH1 Small Molecule: Redefining Hepatocyte Maturation in iPS
2026-06-29
Explore how the FH1 small molecule transforms iPS cell differentiation into mature hepatocyte-like cells, enhancing albumin secretion and CYP3A4 activity. This article uniquely bridges advanced optogenetic gene regulation with practical assay decisions in hepatocyte research.
-
Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237
2026-06-28
The Hoechst 33342/PI Double Staining Kit provides a fluorescence-based method to rapidly differentiate viable, apoptotic, and necrotic cells by assessing nuclear morphology and membrane integrity. This kit is intended for basic research workflows requiring precise cell death mode discrimination and is not suitable for diagnostic or clinical applications.
-
Moxifloxacin for Advanced Antibiotic Toxicity and Metabolic
2026-06-27
Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic from APExBIO, empowers researchers to model antibiotic toxicity, cellular proliferation, and metabolic responses with reproducibility. This guide details optimized workflows, critical troubleshooting, and translational insights, drawing on recent structural and mechanistic advances.
-
Dasatinib Monohydrate in Patient-Derived Cancer Assembloids
2026-06-26
Explore Dasatinib Monohydrate's transformative impact on patient-derived assembloid models for precision cancer research. Gain unique insights into kinase inhibition in complex tumor microenvironments, and discover protocol strategies grounded in recent translational breakthroughs.
-
Antimycin A4 (SKU C8711): Reliable Inhibitor for Metabolic A
2026-06-26
This scenario-driven article addresses real-world laboratory challenges involving cell viability and metabolic assays, demonstrating how Antimycin A4 (SKU C8711) provides reproducible, data-backed solutions. It includes vendor selection insights, protocol optimization, and evidence-based recommendations to help researchers achieve reliable results.
-
Electrical Stimulation Enhances Magnetic Nanoparticle Uptake
2026-06-25
This study introduces alternating current (AC) electrical stimulation as a robust strategy for promoting endocytosis of magnetic nanoparticles (MNPs) across multiple cancer cell lines. The findings demonstrate substantial increases in nanoparticle uptake, with significant practical benefits for magnetic hyperthermia, MRI, and drug delivery applications.
-
FK866 (APO866): Potent NAMPT Inhibitor for AML Research
2026-06-25
FK866 (APO866) is a nanomolar-potency, non-competitive NAMPT inhibitor that selectively depletes NAD in acute myeloid leukemia (AML) cells, sparing normal progenitors. It enables mechanistic dissection of cell death and metabolism in hematologic cancer research.
-
SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in Thymic
2026-06-24
This study identifies SNAI1 as a central regulator of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs) via the PIK3R2/p-EphA2 pathway. By integrating multi-omics, single-cell, and functional assays, the research uncovers actionable molecular mechanisms that could inform new therapeutic approaches targeting SNAI1 in TETs.